MESNA Side Effects

6690736-4 | Febrile Bone Marrow Aplasia, Status Epilepticus
on Apr 14, 2010 Female patient from FRANCE , 66 years of age, was diagnosed with lymphoma (What is lymphoma?) and was treated with Mesna (View Usage). Patient experienced the following unwanted or unexpected effects: febrile bone marrow aplasia, status epilepticus. Mesna dosage: . During the same period patient was treated with HOLOXAN BAXTER (View Holoxan Baxter Review and Holoxan Baxter Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ). Patient was hospitalized.

6554804-X | Encephalopathy
Patient was taking Mesna (View Usage). Patient had the following side effects: encephalopathy on Jan 18, 2010 from FRANCE Additional patient health information: Male patient , 64 years of age, was diagnosed with liposarcoma recurrent and. Mesna dosage: . During the same period patient was treated with HOLOXAN BAXTER (View Holoxan Baxter Review and Holoxan Baxter Label ), ONDANSETRON HCL (View Ondansetron Hcl Review and Ondansetron Hcl Label ). Patient was hospitalized.

6278435-4 | Encephalopathy
Adverse event was reported on Jul 15, 2009 by a Male patient taking Mesna (View Usage) (Dosage: ) was diagnosed with liposarcoma metastatic and. Location: FRANCE , 59 years of age, After Mesna was administered, patient had the following side effects: encephalopathy. During the same period patient was treated with HOLOXAN BAXTER (View Holoxan Baxter Review and Holoxan Baxter Label ), PRIMPERAN (View Primperan Review and Primperan Label ), ONDANSETRON HCL (View Ondansetron Hcl Review and Ondansetron Hcl Label ).

6178853-9 | Convulsion
on Apr 23, 2009 Female patient from ITALY , 16 years of age, was diagnosed with neuroblastoma (What is neuroblastoma?), metastasis and was treated with Mesna (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion. Mesna dosage: . During the same period patient was treated with IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ).


6178852-7 | Convulsion
on Apr 23, 2009 Female patient from ITALY , child 6 years of age, was diagnosed with burkitt's lymphoma and was treated with Mesna (View Usage). Patient had the following side effects: convulsion. Mesna dosage: . During the same period patient was treated with IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ), VINCRISTINE SULFATE (View Vincristine Sulfate Review and Vincristine Sulfate Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ).

6178849-7 | Dizziness, Irritability, Mental Status Changes, Somnolence
Patient was taking Mesna (View Usage). After Mesna was administered, patient had the following side effects: dizziness (What is dizziness?), irritability, mental status changes, somnolence on Apr 23, 2009 from ITALY Additional patient health information: Female patient , child 5 years of age, was diagnosed with acute lymphocytic leukaemia and. Mesna dosage: . During the same period patient was treated with IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ), VINCRISTINE SULFATE (View Vincristine Sulfate Review and Vincristine Sulfate Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ).

6178846-1 | Convulsion
Adverse event was reported on Apr 23, 2009 by a Male patient taking Mesna (View Usage) (Dosage: ) . Location: ITALY , child 9 years of age, Patient experienced the following unwanted or unexpected effects: convulsion. During the same period patient was treated with IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ), VINCRISTINE SULFATE (View Vincristine Sulfate Review and Vincristine Sulfate Label ), ACTINOMYCIN D (View Actinomycin D Review and Actinomycin D Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ).

6178840-0 | Convulsion
on Apr 23, 2009 Female patient from ITALY , child 6 years of age, was diagnosed with ewing's sarcoma and was treated with Mesna (View Usage). Patient had the following side effects: convulsion. Mesna dosage: . During the same period patient was treated with IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ), VINCRISTINE SULFATE (View Vincristine Sulfate Review and Vincristine Sulfate Label ), ACTINOMYCIN D (View Actinomycin D Review and Actinomycin D Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ).

6148809-0 | Glasgow Coma Scale Abnormal, Myoclonic Epilepsy, Neurotoxicity
on Mar 31, 2009 Female patient from AUSTRALIA , 74 years of age, was treated with Mesna (View Usage). After Mesna was administered, patient had the following side effects: glasgow coma scale abnormal, myoclonic epilepsy, neurotoxicity. Mesna dosage: . During the same period patient was treated with IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), SLOW K (View Slow-k Review and Slow-k Label ). Patient was hospitalized.

5921821-X | Cardiac Disorder, Cardiac Failure Congestive, Dyspnoea, Left Ventricular Dysfunction, Platelet Count Decreased, Pleural Effusion
Patient was taking Mesna (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac disorder, cardiac failure congestive, dyspnoea, left ventricular dysfunction, platelet count decreased, pleural effusion on Oct 08, 2008 from UNITED STATES Additional patient health information: Female patient , 58 years of age, was diagnosed with diffuse large b-cell lymphoma and. Mesna dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), CARMUSTINE (View Carmustine Review and Carmustine Label ). Patient was hospitalized.

5840399-2 | Chills, Hypersensitivity, Pyrexia
Adverse event was reported on Jul 23, 2008 by a Female patient taking Mesna (View Usage) (Dosage: 7400 Mg, Over 24 Hours, Intravenous Drip) was diagnosed with cystitis haemorrhagic, prophylaxis, lymphoma (What is lymphoma?) and. Location: UNITED STATES , 69 years of age, weighting 143.0 lb, Patient had the following side effects: chills, hypersensitivity, pyrexia. During the same period patient was treated with IFOSFAMIDE (7400 Mg, Over 24 Hours; Intravenous Drip) (View Ifosfamide Review and Ifosfamide Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), ZOFRAN (View Zofran Review and Zofran Label ), DECADRON (View Decadron Review and Decadron Label ). Patient was hospitalized.

5627097-5 | Extravasation
on Jan 03, 2008 Female patient from UNITED STATES , 76 years of age, weighting 189.6 lb, was diagnosed with haemorrhage and was treated with Mesna (View Usage). After Mesna was administered, patient had the following side effects: extravasation. Mesna dosage: 2000mg/1000ml Ns Over 12 Ho.

5472175-7 | Asthenia, B-cell Lymphoma, Back Pain, Caesarean Section, Diarrhoea, Fatigue, Febrile Neutropenia, Fibrosis
on Sep 10, 2007 Female patient from UNITED STATES , 21 years of age, was diagnosed with burkitt's lymphoma, tumour lysis syndrome, prophylaxis of nausea and vomiting and was treated with Mesna (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, b-cell lymphoma, back pain (What is back pain?), caesarean section, diarrhoea, fatigue, febrile neutropenia, fibrosis. Mesna dosage: 360 Mg/m2 (360 Mg/m2, 1-5 Days) Intravenous (not Otherwise Specified). During the same period patient was treated with IFOSFAMIDE (1500 Mg/m2 (1500 Mg/m2, 1-5 Days) Intravenous (not Otherwise Specified)) (View Ifosfamide Review and Ifosfamide Label ), DOXORUBICIN (INTRAVENOUS INFUSION) (DOXORUBICIN) (40 Mg (40 Mg, 1 In 1 D) Intravenous (not Otherwise Specified)) (View Doxorubicin (intravenous Infusion) (doxorubicin) Review and Doxorubicin (intravenous Infusion) (doxorubicin) Label ), CYTARABINE ((70 Mg, 1 In 1 D) Intrathecal; 12 H (2000 Mg/m2) Intravenous (not Otherwise Specified)) (View Cytarabine Review and Cytarabine Label ), ETOPOSIDE (60 Mg/m2 (60 Mg/m2, 1-5 Days) Intravenous (not Otherwise Specified)) (View Etoposide Review and Etoposide Label ), ALLOPURINOL (600 Mg (300 Mg, 2 In 1 D) Oral) (View Allopurinol Review and Allopurinol Label ), ONDANSETRON HCL (View Ondansetron Hcl Review and Ondansetron Hcl Label ), DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ).

4971364-5 | Clostridium Colitis, Neutropenic Sepsis, Oral Candidiasis, Pancytopenia
Patient was taking Mesna (View Usage). Patient had the following side effects: clostridium colitis, neutropenic sepsis, oral candidiasis, pancytopenia on Mar 30, 2006 from UNITED KINGDOM Additional patient health information: Male patient , 20 years of age, weighting 138.9 lb, was diagnosed with bone sarcoma, neutropenia, pain (What is pain?), malaise and. Mesna dosage: . During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ), IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ), NEULASTA (View Neulasta Review and Neulasta Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), TRAMADOL (View Tramadol Review and Tramadol Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ). Patient was hospitalized.

4962520-0 | Clostridium Colitis, Neutropenic Sepsis, Oral Candidiasis, Pancytopenia
Adverse event was reported on Mar 30, 2006 by a Male patient taking Mesna (View Usage) (Dosage: ) was diagnosed with bone sarcoma, neutropenia, pain (What is pain?), malaise and. Location: UNITED KINGDOM , 20 years of age, weighting 138.9 lb, After Mesna was administered, patient had the following side effects: clostridium colitis, neutropenic sepsis, oral candidiasis, pancytopenia. During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ), IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ), NEULASTA (View Neulasta Review and Neulasta Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ). Patient was hospitalized.

4930691-8 | Abdominal Pain, Diarrhoea, Syncope Vasovagal, Vomiting
on Jan 05, 2006 Male patient from UNITED STATES , 72 years of age, weighting 152.1 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mesna (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), diarrhoea, syncope vasovagal, vomiting. Mesna dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ).

4881827-9 | Abdominal Pain, Blood Pressure Decreased, Diarrhoea, Vomiting
on Jan 05, 2006 Male patient from UNITED STATES , 72 years of age, weighting 152.1 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mesna (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), blood pressure decreased, diarrhoea, vomiting. Mesna dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ).

4831983-3 | Asthma, Overdose
Patient was taking Mesna (View Usage). After Mesna was administered, patient had the following side effects: asthma (What is asthma?), overdose on Nov 16, 2005 from UNITED STATES Additional patient health information: Male patient , 20 years of age, was diagnosed with medulloblastoma and. Mesna dosage: . During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), DOLASETRON (View Dolasetron Review and Dolasetron Label ).

4761171-0 | Cerebral Ischaemia, Diarrhoea, Hemiparesis, Nausea, Pyrexia
Adverse event was reported on Sep 02, 2005 by a Female patient taking Mesna (View Usage) (Dosage: 500mg/m2 Every 4 Weeks Iv) was diagnosed with spindle cell sarcoma and. Location: UNITED STATES , weighting 189.4 lb, Patient experienced the following unwanted or unexpected effects: cerebral ischaemia, diarrhoea, hemiparesis, nausea (What is nausea?), pyrexia. During the same period patient was treated with IFOS (2500mg/m2 Every 4 Weeks Iv) (View Ifos Review and Ifos Label ), TYLENOL (View Tylenol Review and Tylenol Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), PROZAC (View Prozac Review and Prozac Label ), LIPITOR (View Lipitor Review and Lipitor Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), TRIAMTERE (View Triamtere Review and Triamtere Label ), ATENOLOL (View Atenolol Review and Atenolol Label ). Patient was hospitalized.

4648335-1 | Febrile Neutropenia, Haemoglobin Decreased, Platelet Count Abnormal
on Apr 27, 2005 Male patient from , 45 years of age, was diagnosed with sarcoma and was treated with Mesna (View Usage). Patient had the following side effects: febrile neutropenia, haemoglobin decreased, platelet count abnormal. Mesna dosage: Every 3 Weeks 12 Doses Over 4 Days. During the same period patient was treated with EPIRUBICIN (Every 3 Weeks Qd X 4 Days) (View Epirubicin Review and Epirubicin Label ), IFOSFAMIDE (4300 Mg X 4 Days Every 3 Weeks) (View Ifosfamide Review and Ifosfamide Label ). Patient was hospitalized.